Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin

Vancomycin is an increasingly important option for the treatment of Clostridium difficile infection, but economic barriers to its use remain significant in the outpatient setting. Generic vancomycin capsules are still inexplicably expensive and not universally covered by insurers. This report highli...

Descripción completa

Detalles Bibliográficos
Autores principales: Bunnell, Kristen L., Danziger, Larry H., Johnson, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472230/
https://www.ncbi.nlm.nih.gov/pubmed/28638841
http://dx.doi.org/10.1093/ofid/ofx078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472230/
https://www.ncbi.nlm.nih.gov/pubmed/28638841
http://dx.doi.org/10.1093/ofid/ofx078

Ejemplares similares